Kraj: Kanada
Język: angielski
Źródło: Health Canada
SOYBEAN OIL; EGG PHOSPHOLIPIDS
HOSPIRA HEALTHCARE ULC
B05BA02
FAT EMULSIONS
200MG; 12MG
EMULSION
SOYBEAN OIL 200MG; EGG PHOSPHOLIPIDS 12MG
INTRAVENOUS
500ML
Ethical
CALORIC AGENTS
Active ingredient group (AIG) number: 0224198002; AHFS:
CANCELLED POST MARKET
2016-07-29
PRODUCT MONOGRAPH LIPOSYN TM III 10% LIPOSYN TM III 20% (soybean oil and egg phosphatide emulsion for injection) 10/1.2% w/v 20/1.2% w/v Intravenous Nutrient Supplement Hospira Healthcare Corporation Date of preparation: April 14, 2011 111 Dr. Frederik Philips, suite 600 Saint-Laurent, Quebec H4M 2X6 Control # 141415 NAMES OF DRUG LIPOSYN TM III 10% LIPOSYN TM III 20% (soybean oil and egg phosphatide emulsion for injection) 10/1.2% w/v 20/1.2% w/v THERAPEUTIC CLASSIFICATION Intravenous Nutrient Supplement ACTION LIPOSYN TM III 10% and 20% (soybean oil and egg phosphatide emulsion for injection) provides the patient requiring parenteral nutrition with a source of calories and the essential fatty acids normally obtained from a nutritionally complete oral diet. The supplemental polyunsaturated fat prevents biochemical changes of essential fatty acid deficiency (EFAD) and prevents and reverses EFAD clinical manifestations (scaliness of skin, growth retardation, poor wound healing, sparse hair growth). The infused fat particles are cleared from the bloodstream in a manner thought to be similar to the clearing of chylomicrons. INDICATIONS AND CLINICAL USE LIPOSYN TM III 10% and 20% (soybean oil and egg phosphatide emulsion for injection) are indicated as sources of calories for patients requiring parenteral nutrition. This includes pre- and post-operative nutritional disorders and nutritive disorders resulting from decreased or inhibited intestinal absorption, as with tumours of the digestive tract, or in ulcerative colitis and terminal ileitis. LIPOSYN TM III 10% and 20% are also indicated in burn cases, where nitrogen loss can be excessive, in prolonged states of unconsciousness if tube feeding is inadvisable and in cachexia due to serious diseases other than of the alimentary tract. Where such nutrition is required for extended periods of time (more than five days), LIPOSYN TM III 10% and 20% are also indicated as sources of essential fatty acids to prevent or reverse biochemical changes in fatty acid composition of Przeczytaj cały dokument